These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 22964963)

  • 1. Pancreatitis during treatment with liraglutide.
    Famularo G; Gasbarrone L; Minisola G
    JOP; 2012 Sep; 13(5):540-1. PubMed ID: 22964963
    [No Abstract]   [Full Text] [Related]  

  • 2. Acute pancreatitis associated with liraglutide.
    Lee PH; Stockton MD; Franks AS
    Ann Pharmacother; 2011 Apr; 45(4):e22. PubMed ID: 21487080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liraglutide-induced acute pancreatitis.
    Jeyaraj S; Shetty AS; Kumar CR; Nanditha A; Krishnamoorthy S; Raghavan A; Raghavan K; Ramachandran A
    J Assoc Physicians India; 2014 Jan; 62(1):64-6. PubMed ID: 25327099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Late and severe acute necrotizing pancreatitis in a patient with liraglutide.
    Bourezane H; Kastler B; Kantelip JP
    Therapie; 2012; 67(6):539-43. PubMed ID: 23249582
    [No Abstract]   [Full Text] [Related]  

  • 5. Novo Nordisk replies to BMJ investigation on incretins and pancreatic damage.
    Moses A
    BMJ; 2013 Jul; 347():f4386. PubMed ID: 23842435
    [No Abstract]   [Full Text] [Related]  

  • 6. Weighing risks and benefits of liraglutide--the FDA's review of a new antidiabetic therapy.
    Parks M; Rosebraugh C
    N Engl J Med; 2010 Mar; 362(9):774-7. PubMed ID: 20164475
    [No Abstract]   [Full Text] [Related]  

  • 7. Pancreatitis: a potential complication of liraglutide?
    Franks AS; Lee PH; George CM
    Ann Pharmacother; 2012 Nov; 46(11):1547-53. PubMed ID: 23136352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Acute pancreatitis in a patient treated with liraglutide].
    Artero A; Bourguet M; Lorente RI; Real JT
    Med Clin (Barc); 2013 Oct; 141(8):368-9. PubMed ID: 23507272
    [No Abstract]   [Full Text] [Related]  

  • 9. [Liraglutide: a human GLP-1 analogue for the treatment of diabetes mellitus type 2].
    Jahn E; Sausele T
    Med Monatsschr Pharm; 2009 Nov; 32(11):402-7. PubMed ID: 19947303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A meta-analysis of serious adverse events reported with exenatide and liraglutide: acute pancreatitis and cancer.
    Alves C; Batel-Marques F; Macedo AF
    Diabetes Res Clin Pract; 2012 Nov; 98(2):271-84. PubMed ID: 23010561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liraglutide-associated acute pancreatitis.
    Knezevich E; Crnic T; Kershaw S; Drincic A
    Am J Health Syst Pharm; 2012 Mar; 69(5):386-9. PubMed ID: 22345417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liraglutide (Victoza) for type 2 diabetes.
    Med Lett Drugs Ther; 2010 Apr; 52(1335):25-7. PubMed ID: 20360660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Q: Do incretin drugs for type 2 diabetes increase the risk of acute pancreatitis?
    Olansky L
    Cleve Clin J Med; 2010 Aug; 77(8):503-5. PubMed ID: 20682512
    [No Abstract]   [Full Text] [Related]  

  • 14. A review of efficacy and safety data regarding the use of liraglutide, a once-daily human glucagon-like peptide 1 analogue, in the treatment of type 2 diabetes mellitus.
    Montanya E; Sesti G
    Clin Ther; 2009 Nov; 31(11):2472-88. PubMed ID: 20109994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vesiculopustular dermatosis: an uncommon side-effect of liraglutide?
    Besemer F; Verschoor AJ; Diamant M; Hoogma RP
    J Diabetes Complications; 2012; 26(5):458-9. PubMed ID: 22727533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liraglutide. Type 2 diabetes: more prudent to continue using exenatide.
    Prescrire Int; 2010 Jun; 19(107):109-12. PubMed ID: 20738033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucagon-like peptide-1 analogues for type 2 diabetes.
    Wilding JP; Hardy K
    BMJ; 2011 Feb; 342():d410. PubMed ID: 21325387
    [No Abstract]   [Full Text] [Related]  

  • 18. Patient-reported rating of gastrointestinal adverse effects during treatment of type 2 diabetes with the once-daily human GLP-1 analogue, liraglutide.
    Horowitz M; Vilsbøll T; Zdravkovic M; Hammer M; Madsbad S
    Diabetes Obes Metab; 2008 Jul; 10(7):593-6. PubMed ID: 18435773
    [No Abstract]   [Full Text] [Related]  

  • 19. The effects of liraglutide on male fertility: a case report.
    Fontoura P; Cardoso MC; Erthal-Martins MC; Werneck C; Sartorio C; Ramos CF
    Reprod Biomed Online; 2014 Nov; 29(5):644-6. PubMed ID: 25246122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of pancreatitis with glucagon-like peptide-1 agonist use.
    Anderson SL; Trujillo JM
    Ann Pharmacother; 2010 May; 44(5):904-9. PubMed ID: 20371755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.